Skip to search formSkip to main contentSkip to account menu

LY395756

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of…
2015
2015
LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801…
2014
2014
Age-dependent Effects of mGluR2 Agonist LY395756 on NMDA Receptor Expression and Function in the Rat Prefrontal Cortex
2013
2013
Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala
2013
2013
Group II Metabotropic Glutamate Receptor Agonist LY379268 Regulates AMPA Receptor Trafficking in Prefrontal Cortical Neurons
Group II metabotropic glutamate receptor (mGluR) agonists have emerged as potential treatment drugs for schizophrenia and other… 
2011
2011
Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype
Group II metabotropic receptors (mGluRs) regulate central synaptic transmission by modulating neurotransmitter release. However… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License